Charles River Laboratories CRL Europe — Long-Lived Assets
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:NoncurrentAssets.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's europe — long-lived assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's europe — long-lived assets?
- Charles River Laboratories (CRL) reported europe — long-lived assets of $450.34M in Q1 2026.
- How has Charles River Laboratories's europe — long-lived assets changed year-over-year?
- Charles River Laboratories's europe — long-lived assets increased by 5.4% year-over-year, from $427.21M to $450.34M.
- What does europe — long-lived assets mean?
- The total value of long-term physical and intangible assets held by the company in Europe.
- How do you interpret europe — long-lived assets?
- An increase suggests ongoing capital investment and expansion of regional capacity, whereas a decrease may indicate asset divestiture, impairment, or a shift in operational strategy.
- How does europe — long-lived assets compare across companies?
- Similar to other global life sciences companies, this metric is used to evaluate the geographic distribution of capital intensity and operational infrastructure.